TableĀ 2.
Anticipated benefits for MND practice and policy
Stakeholder group | Benefit |
---|---|
Patients |
|
| |
| |
Health professionals |
|
| |
| |
| |
Health services |
|
| |
| |
| |
Healthcare policy |
|
| |
| |
Research community |
|
| |
|
MND, motor neurone disease.
Anticipated benefits for MND practice and policy
Stakeholder group | Benefit |
---|---|
Patients |
|
| |
| |
Health professionals |
|
| |
| |
| |
Health services |
|
| |
| |
| |
Healthcare policy |
|
| |
| |
Research community |
|
| |
|
MND, motor neurone disease.